Regaining Function After Spinal Cord Injury: A New Path Forward? Dr. Adam Rogers, CEO, NervGen Pharma
On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, some trial participants have seen increased function as much as 10 years post-trauma.
